CLBR.WS_OUT_1 [2025-04-28 13:26:32 -0400] 2223 Bytes | 560 tokens | Cum: 560 tkns (7.00% of 8k)
==========================================================================

Booyah, my friends! It's already 1:26 PM on Mon Apr 28, 2025, and I've got my eyes locked on Colombier Acquisition (CLBR.WS), pushing up to $1.35 from $1.15. Are we in for a serious bull run, or is this just hype? I've pulled the data—let's break it down!

--- COMPANY PROFILE ---
Company: Colombier Acquisition (CLBR.WS)
IPO: 2024-01-11 (1 Year Ago)
Industry: BLANK CHECKS
Exchange: XNYS
Description: Colombier Acquisition Corp II is a blank check company.

Here’s a list of headlines for Colombier Acquisition:

No news available.

Here's another list of headlines with menu handles.
I will deliver the full text of the following stories when you say their handle.
Just say, for example, B1, B2, etc.

B1 - 2025-01-10T14:55:00Z - SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates GETY, CLBR, VINC, NEUE on Behalf of Shareholders
B2 - 2025-01-10T14:37:00Z - Kuehn Law Encourages VINC, NEUE, GETY, and CLBR Investors to Contact Law Firm

==============
-> THE ROLE FOR AI:
==============

1) You are the **AI analyst-investigator**, and this interaction represents a full **due diligence session** for Colombier Acquisition (CLBR.WS).
Due diligence includes financial data, insider trading, relevant news, and any SEC filings — and may extend beyond classic fundamentals.
Your task is to identify whether this stock has momentum and potential.

2) I am **ScanScor**, a unified report generator that archives this session as part of our real-time diligence record.

3) You will request information by referencing documents by their code.

4) As the analysis proceeds, your are encouraged to review documents until you feel confident in your judgment.
After seeing 3 sets of news articles, SEC docs, and financials, you'll be prompted to return some data pairs.

5) News articles, SEC filings, and key metrics will be revealed in subsequent prompts.

Stay focused. Gather evidence. Continue until your conclusions are clear.
Restrict all your responses to just 3 tokens until the summary and data pairs at the end.

NEXT: Request a document with its reference code(s), such as:
- `B1`, `B2`, `B3`, etc.
- To load a new set of information and menu options, reply with: `NEX`

CLBR.WS_OUT_3 [2025-04-28 13:26:32 -0400] 922 Bytes | 254 tokens | Cum: 816 tkns (10.20% of 8k)
==========================================================================

Showing B1 (chunk 1 of 1): B1:
**SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates GETY, CLBR, VINC, NEUE on Behalf of Shareholders**Date: Unknown DateSource: Unknown SourceURL: https://www.globenewswire.com/news-release/2025/01/10/3007786/0/en/SHAREHOLDER-NOTICE-Halper-Sadeh-LLC-Investigates-GETY-CLBR-VINC-NEUE-on-Behalf-of-Shareholders.htmlHalper Sadeh LLC, an investor rights law firm, is investigating potential violations of federal securities laws and breaches of fiduciary duties to shareholders in several merger and acquisition transactions, including Getty Images Holdings, Inc., Colombier Acquisition Corp. II, Vincerx Pharma, Inc., and NeueHealth, Inc.

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

CLBR.WS_OUT_5 [2025-04-28 13:26:33 -0400] 380 Bytes | 87 tokens | Cum: 905 tkns (11.31% of 8k)
==========================================================================

We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.

Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.

CLBR.WS_OUT_7 [2025-04-28 13:26:35 -0400] 336 Bytes | 98 tokens | Cum: 1005 tkns (12.56% of 8k)
==========================================================================

Showing A1 (chunk 1 of 1): A1:
Document A1 not found. Only 0 articles available.

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

CLBR.WS_OUT_9 [2025-04-28 13:26:36 -0400] 238 Bytes | 59 tokens | Cum: 1066 tkns (13.33% of 8k)
==========================================================================

This is our list of SEC filings.
If empty, the search returned no recent filings.

Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

CLBR.WS_OUT_11 [2025-04-28 13:26:37 -0400] 251 Bytes | 78 tokens | Cum: 1147 tkns (14.34% of 8k)
==========================================================================

You just read a chunk of S1.
You may now:
- Say "MOR" to continue this article
- Say "S2", "S3", etc. to request another
- Or say "NEX" to move to the next source

You are allowed up to 6 articles from this list. If you’re ready to move on, say NEX.

CLBR.WS_OUT_13 [2025-04-28 13:26:44 -0400] 4066 Bytes | 1088 tokens | Cum: 2238 tkns (27.98% of 8k)
==========================================================================

This is our set of metrics for Colombier Acquisition.
Please analyze the numbers.

No Finviz metrics available.

The next section covers any insider trading by Colombier Acquisition officers or majority shareholders (if available).

[Company Financial Summary]
[Company Details]
Name: N/A
Market Cap: N/A
Shares Outstanding: N/A
Sector: N/A

[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): N/A
Net Income: {'value': 5758466.0, 'unit': 'USD', 'label': 'Net Income/Loss', 'order': 3200}
Earnings Per Share (EPS): N/A

[Price Metrics - Last 30 Days]
Latest Close: 1.38
Average Volume: 95048.5
30-Day High: 1.38
30-Day Low: 0.7266

[Detailed Financials: TTM 2024]
- Total Assets: $178,880,310.00
- Total Liabilities: $6,684,555.00
- Total Equity: $-5,438,962.00
- Current Assets: $1,245,593.00
- Current Liabilities: $734,555.00

[Income Statement: TTM 2024]
- Revenue: N/A
- Net Income: $5,758,466.00
- Gross Profit: N/A
- Operating Income: $-3,019,794.00
- Earnings Per Share (EPS): N/A

[Cash Flow Statement: TTM 2024]
- Net Cash Flow: $-387,867.00

[Detailed Financials: FY 2024]
- Total Assets: $178,880,310.00
- Total Liabilities: $6,684,555.00
- Total Equity: $-5,438,962.00
- Current Assets: $1,245,593.00
- Current Liabilities: $734,555.00

[Income Statement: FY 2024]
- Revenue: N/A
- Net Income: $5,758,466.00
- Gross Profit: N/A
- Operating Income: $-3,019,794.00
- Earnings Per Share (EPS): N/A

[Cash Flow Statement: FY 2024]
- Net Cash Flow: $-387,867.00
==== END OF FINANCIAL REPORT ====

You are now requested to write a summary analysis of Colombier Acquisition (CLBR.WS).

Please complete the report using the exact format:
FIELD[value]

1) BRIEF_SUMMARY[]
One well-worded paragraph summarizing your findings about Colombier Acquisition.

2) MARKET_SCORE[]
This conversation was initiated because CLBR.WS is currently experiencing upward price and volume movement.
Estimate a number between 1–100 based on the likelihood of a continued upward price move for CLBR.WS.
Weigh relevant data — news, filings, fundamentals, and metrics — and assign appropriate weight.

3) PRICE_TARGET[]
Suggest a price, based on all prior evidence and past price behavior, CLBR.WS could reach in the current or upcoming trading sessions (1–5 days).
For example, if you expect CLBR.WS to increase 50% from its current price of $0.00, say: PRICE_TARGET[0.0]

4) AI_RPT_HEADLINE[]
Write a thought-provoking 8–12 word headline summarizing this report.

5) SQUEEZE_POTENTIAL[]
Give a score from 1 to 100 representing the potential for this stock to become an active short squeeze play.
Be honest and unbiased. Consider short interest/float, price movement, volume, news strength, and volatility potential.

6) TAGS[]
List 3–6 comma-separated tags (e.g., biotech, earnings beat, squeeze setup)

7) STOCK_TYPE[]
Choose the most accurate classification: growth, value, turnaround, hype, squeeze, dividend, speculative, or other.

8) PRIMARY_CATALYST[]
e.g., earnings report, FDA approval, partnership, etc.

9) SENTIMENT[]
bullish, bearish, neutral, or mixed

10) IMPROVEMENT_SUGGESTION[]
If you believe some key info was missing, state what would have significantly improved your analysis of Colombier Acquisition.

11) ETHICAL_RATING[]
Rate Colombier Acquisition’s alignment with long-term shareholder interests, using a letter grade from A (high alignment) to F (low alignment).
Base this on actions such as insider buying/selling, share dilution, follow-through on public statements, and compensation practices.

12) UPCOMING_CATALYST[]
Specify any upcoming events you expect would be a catalyst affecting the share-price of Colombier Acquisition.
Provide any reasons you can use to support it.

Return only: FIELD[value] for each of the above 12 questions.
Respond with all data pairs. Take your best guess if you have to, but don't leave blank items.
Do not explain your answers. Return only the required fields in the exact format shown.

Finally, thank you for participating!

CLBR.WS_IN_15 [2025-04-28 13:26:44 -0400] 126 Bytes | 29 tokens | Cum: 2518 tkns (31.47% of 8k)
==========================================================================

====================================
[2025-04-28 13:26:44] # Analysis Completed
Elapsed Time: 13.25 seconds